147 related articles for article (PubMed ID: 35946523)
1. LncRNA ST8SIA6-AS1 facilitates hepatocellular carcinoma progression by governing miR-651-5p/TM4SF4 axis.
Mou Y; Ding X
Anticancer Drugs; 2022 Sep; 33(8):741-751. PubMed ID: 35946523
[TBL] [Abstract][Full Text] [Related]
2. ST8SIA6-AS1 promotes the development of hepatocellular carcinoma cells through miR-338-3p/NONO Axis.
Kuai J; Zheng L; Yi X; Liu Z; Qiu B; Lu Z; Jiang Y
Dig Liver Dis; 2021 Sep; 53(9):1192-1200. PubMed ID: 33722502
[TBL] [Abstract][Full Text] [Related]
3. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma progression by regulating MAGEA3 and DCAF4L2 expression.
Zhang X; Xu S; Hu C; Fang K; Zhou J; Guo Z; Zhu G; Li L
Biochem Biophys Res Commun; 2020 Dec; 533(4):1039-1047. PubMed ID: 33012505
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
Qiao Y; Wang B; Yan Y; Niu L
Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
[TBL] [Abstract][Full Text] [Related]
6. ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6.
Li Y; Jiang A
Cancer Biol Ther; 2020 Jul; 21(7):647-655. PubMed ID: 32420798
[TBL] [Abstract][Full Text] [Related]
7. ST8SIA6-AS1 contributes to hepatocellular carcinoma progression by targeting miR-142-3p/HMGA1 axis.
Feng T; Yao Y; Luo L; Zou H; Xiang G; Wei L; Yang Q; Shi Y; Huang X; Lai C
Sci Rep; 2023 Jan; 13(1):650. PubMed ID: 36635290
[TBL] [Abstract][Full Text] [Related]
8. MCF2L-AS1 promotes the biological behaviors of hepatocellular carcinoma cells by regulating the miR-33a-5p/FGF2 axis.
Ou H; Qian Y; Ma L
Aging (Albany NY); 2023 Jul; 15(13):6100-6116. PubMed ID: 37432067
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
[TBL] [Abstract][Full Text] [Related]
10. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
[TBL] [Abstract][Full Text] [Related]
11. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
12. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
[TBL] [Abstract][Full Text] [Related]
13. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
Huang C; Li K; Huang R; Zhu J; Yang J
Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA HAND2-AS1 reduced the viability of hepatocellular carcinoma via targeting microRNA-300/SOCS5 axis.
Bi HQ; Li ZH; Zhang H
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):567-574. PubMed ID: 32224127
[TBL] [Abstract][Full Text] [Related]
15. The long non-coding RNA ASMTL-AS1 promotes hepatocellular carcinoma progression by sponging miR-1343-3p that suppresses LAMC1 (laminin subunit gamma 1).
Mou Y; Sun Q
Bioengineered; 2022 Jan; 13(1):746-758. PubMed ID: 34859735
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
[TBL] [Abstract][Full Text] [Related]
18. LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway.
Wan T; Zheng J; Yao R; Yang S; Zheng W; Zhou P
Ann Hepatol; 2021; 20():100258. PubMed ID: 32961346
[TBL] [Abstract][Full Text] [Related]
19. ZSCAN16-AS1 expedites hepatocellular carcinoma progression via modulating the miR-181c-5p/SPAG9 axis to activate the JNK pathway.
Liu J; Liu R; Liu Y; Li L; Cao H; Liu J; Cao G
Cell Cycle; 2021 Jun; 20(12):1134-1146. PubMed ID: 34097562
[TBL] [Abstract][Full Text] [Related]
20. Profiling of specific long non-coding RNA signatures identifies ST8SIA6-AS1 AS a novel target for breast cancer.
Chen Z; Huang J; Feng Y; Li Z; Jiang Y
J Gene Med; 2021 Feb; 23(2):e3286. PubMed ID: 33037712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
